Role of miRNAs in Cancer Analysis of Their Targetome
MicroRNAs are the best representatives of the non-coding part of the genome and their functions are mostly linked to their target genes. During the process of carcinogenesis, both dysregulation of microRNAs and their target genes can explain the development of the disease. However, most of the targe...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_81171 | ||
| 005 | 20220506 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220506s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-1685-1 | ||
| 020 | |a 9783036516868 | ||
| 020 | |a 9783036516851 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1685-1 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 100 | 1 | |a Navarro, Alfons |4 edt | |
| 700 | 1 | |a Navarro, Alfons |4 oth | |
| 245 | 1 | 0 | |a Role of miRNAs in Cancer |b Analysis of Their Targetome |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (302 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a MicroRNAs are the best representatives of the non-coding part of the genome and their functions are mostly linked to their target genes. During the process of carcinogenesis, both dysregulation of microRNAs and their target genes can explain the development of the disease. However, most of the target genes of microRNAs have not yet been elucidated. In this book, we add new information related to the functions of microRNAs in various tumors and their associated targetome. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Oncology |2 bicssc | |
| 653 | |a miR526b | ||
| 653 | |a miR655 | ||
| 653 | |a breast cancer | ||
| 653 | |a angiogenesis | ||
| 653 | |a lymphangiogenesis | ||
| 653 | |a EP4 | ||
| 653 | |a PI3K/Akt | ||
| 653 | |a microRNA-361 | ||
| 653 | |a EMT | ||
| 653 | |a tumor microenvironment | ||
| 653 | |a cancer diagnosis | ||
| 653 | |a cancer treatment | ||
| 653 | |a Bladder cancer | ||
| 653 | |a microRNA | ||
| 653 | |a genetic marker | ||
| 653 | |a progression | ||
| 653 | |a ccRCC | ||
| 653 | |a prognostic biomarker | ||
| 653 | |a miRNA | ||
| 653 | |a transcription factor | ||
| 653 | |a interplay | ||
| 653 | |a microRNAs | ||
| 653 | |a exosomes | ||
| 653 | |a liquid biopsy | ||
| 653 | |a metastasis | ||
| 653 | |a cancer | ||
| 653 | |a liquid biopsies | ||
| 653 | |a tumor | ||
| 653 | |a SNAIL (SNAI1) transcription factor | ||
| 653 | |a epithelial to mesenchymal transition (EMT) | ||
| 653 | |a long non-coding RNAs (lncRNAs) | ||
| 653 | |a circular RNAs | ||
| 653 | |a viral miRNAs | ||
| 653 | |a EBV | ||
| 653 | |a HHV-8 | ||
| 653 | |a HPV | ||
| 653 | |a HCV | ||
| 653 | |a HBV | ||
| 653 | |a MCPyV | ||
| 653 | |a glioblastoma | ||
| 653 | |a MGMT | ||
| 653 | |a survival | ||
| 653 | |a radiotherapy | ||
| 653 | |a chemotherapy | ||
| 653 | |a temozolomide | ||
| 653 | |a translational medicine | ||
| 653 | |a oncomiRNA | ||
| 653 | |a post-transcriptional regulation | ||
| 653 | |a immune regulation | ||
| 653 | |a adrenocortical carcinoma | ||
| 653 | |a micro RNA | ||
| 653 | |a non-coding RNA | ||
| 653 | |a thyroid carcinoma | ||
| 653 | |a radioactive iodine | ||
| 653 | |a drug resistance | ||
| 653 | |a prognosis | ||
| 653 | |a Burkitt lymphoma | ||
| 653 | |a miR-378a-3p | ||
| 653 | |a cell growth | ||
| 653 | |a pancreatic cancer | ||
| 653 | |a radioresistance | ||
| 653 | |a personalized medicine | ||
| 653 | |a biomarker | ||
| 653 | |a target | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5202 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/81171 |7 0 |z DOAB: description of the publication |